Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Total nitric oxide and inducible nitric oxide synthase in alcohol-dependent individuals during detoxification therapy.

Zoga M, Tzavellas E, Ioannidis A, Karaiskos D, Paparrigopoulos T, Liappas I, Pliatsika P, Nikolaou C, Chatzipanagiotou S.

In Vivo. 2014 Nov-Dec;28(6):1175-9.

PMID:
25398819
2.

Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.

Tzavellas E, Karaiskos D, Ilias I, Liappas I, Paparrigopoulos T.

Psychiatriki. 2014 Jul-Sep;25(3):179-84.

PMID:
25367661
3.

Increased co-morbidity of depression and post-traumatic stress disorder symptoms and common risk factors in intensive care unit survivors: a two-year follow-up study.

Paparrigopoulos T, Melissaki A, Tzavellas E, Karaiskos D, Ilias I, Kokras N.

Int J Psychiatry Clin Pract. 2014 Jan;18(1):25-31. doi: 10.3109/13651501.2013.855793. Epub 2014 Jan 17.

PMID:
24151923
4.

Paliperidone-induced tardive dystonia: a case report.

Havaki-Kontaxaki B, Karaiskos D, Pappa D, Papadimitriou GN.

J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):E51. doi: 10.1176/appi.neuropsych.12050119. No abstract available.

PMID:
23686064
5.

Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus.

Karaiskos D, Tzavellas E, Ilias I, Liappas I, Paparrigopoulos T.

Int J Clin Pract. 2013 Mar;67(3):257-60. doi: 10.1111/ijcp.12112.

PMID:
23409693
6.

Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.

Karaiskos D, Tzavellas E, Spengos K, Vassilopoulou S, Paparrigopoulos T.

J Neuropsychiatry Clin Neurosci. 2012 Summer;24(3):349-53. doi: 10.1176/appi.neuropsych.11110325.

PMID:
23037649
7.

Glandular cystitis and lithium intoxication in a patient with bipolar disorder.

Havaki-Kontaxaki B, Ferentinos P, Karaiskos D, Pappa D, Papadimitriou G.

Psychiatriki. 2012 Apr-Jun;23(2):158-61.

PMID:
22796915
8.

Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder-an open-label study.

Karaiskos D, Pappa D, Tzavellas E, Siarkos K, Katirtzoglou E, Papadimitriou GN, Politis A.

Int J Geriatr Psychiatry. 2013 Jan;28(1):100-5. doi: 10.1002/gps.3800. Epub 2012 Mar 20.

PMID:
22431439
9.

[The spectrum of Tourette Syndrome and difficulties in differential diagnosis: a case report].

Persefonis G, Karaiskos D, Tzavelas E, Paparrigopoulos T.

Psychiatriki. 2011 Jul-Sep;22(3):249-53. Greek, Modern.

PMID:
21971200
10.

IGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects.

Ilias I, Paparrigopoulos T, Tzavellas E, Karaiskos D, Kontoleon P, Liappas I.

Med Sci Monit. 2011 Oct;17(10):CR547-51.

11.

Inpatient alcohol detoxification and plasma calcitonin (with original findings).

Ilias I, Paparrigopoulos T, Tzavellas E, Karaiskos D, Meristoudis G, Liappas A, Liappas I.

Hell J Nucl Med. 2011 May-Aug;14(2):177-8. No abstract available.

PMID:
21761025
12.

Paliperidone-induced obsessive symptoms.

Paparrigopoulos T, Tzavellas E, Karaiskos D, Liappas I.

J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):E46. doi: 10.1176/appi.neuropsych.23.2.E46. No abstract available.

PMID:
21677227
13.

Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study.

Paparrigopoulos T, Tzavellas E, Karaiskos D, Kourlaba G, Liappas I.

BMC Psychiatry. 2011 Mar 14;11:41. doi: 10.1186/1471-244X-11-41.

14.

Acute eosinophilic pneumonia after venlafaxine overdose.

Paparrigopoulos T, Tzavellas E, Karaiskos D, Ilias I, Liappas I.

J Clin Psychopharmacol. 2011 Apr;31(2):258-9. doi: 10.1097/JCP.0b013e31820fbecd. No abstract available.

PMID:
21364346
15.

Alteration of biological markers in alcohol-dependent individuals without liver disease during the detoxification therapy.

Chatzipanagiotou S, Kalykaki M, Tzavellas E, Karaiskos D, Paparrigopoulos T, Liappas A, Nicolaou C, Michalopoulou M, Zoga M, Boufidou F, Liappas I.

In Vivo. 2010 May-Jun;24(3):325-8.

PMID:
20555007
16.

Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptides.

Karaiskos D, Mavragani CP, Sinno MH, D├ęchelotte P, Zintzaras E, Skopouli FN, Fetissov SO, Moutsopoulos HM.

Rheumatology (Oxford). 2010 Sep;49(9):1762-9. doi: 10.1093/rheumatology/keq158. Epub 2010 Jun 4.

17.

Complete recovery from undertreated Wernicke-Korsakoff syndrome following aggressive thiamine treatment.

Paparrigopoulos T, Tzavellas E, Karaiskos D, Kouzoupis A, Liappas I.

In Vivo. 2010 Mar-Apr;24(2):231-3.

PMID:
20364001
18.

Can quetiapine-induced hypothyroidism be reversible without quetiapine discontinuation?

Kontaxakis VP, Karaiskos D, Havaki-Kontaxaki BJ, Ferentinos P, Papadimitriou GN.

Clin Neuropharmacol. 2009 Sep-Oct;32(5):295-6. doi: 10.1097/WNF.0b013e3181a8cbcc.

PMID:
19820433
19.

An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects.

Paparrigopoulos T, Tzavellas E, Karaiskos D, Malitas P, Liappas I.

J Psychopharmacol. 2010 Sep;24(9):1375-80. doi: 10.1177/0269881109103799. Epub 2009 Apr 3.

PMID:
19346278
20.

Triglycerides, depression, and risk of ischemic stroke.

Tzavellas E, Karaiskos D, Paparrigopoulos T.

JAMA. 2009 Apr 1;301(13):1338-9; author reply 1339. doi: 10.1001/jama.2009.410. No abstract available.

PMID:
19336707
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk